قالب وردپرس درنا توس
Home / Health / FDA commissioner refuses to oppose Trump on hydroxychloroquine – Raw Story

FDA commissioner refuses to oppose Trump on hydroxychloroquine – Raw Story



President Donald Trump, head of the Food and Drug Administration, declined to say that hydroxychloroquine should not be used to treat coronavirus.

The FDA revoked the emergency use permit for hydroxychloroquine on June 15 and issued a new warning about the potential side effects of the drug, but Commissioner Dr. Stephen Hahn told NBC “Today” that it could still be prescribed for the treatment of COVID-19.

“I have to ask you about hydroxychloroquine,” said host Savannah Guthrie. “It’s in the news again.” The president reformulated the video promoting it, even saying, “I took it for 14 days and I’m here. I don̵

7;t think you’ll lose anything. “The vice president said yesterday,” Many Americans have had a positive experience with hydrochloroquine. ” “

“Should people take hydroxychloroquine once and for all?” she added.

Hahn refused to oppose President and Vice President Mike Pence.

“To make it clear, at the request of another government agency, BARDA (Biomedical Advance Research and Development Authority), we revoked the EUA’s emergency use permit,” Hahn said. “This has been approved for sick hospitalized patients. We had data that when this medicine was combined with others, there were some risks involved. But the question you ask me is a decision between a doctor and a patient. The physician and patient must evaluate the data there. The FDA does not regulate medical practice. This is where this decision should be made in the privacy of the doctor / patient relationship. ‘ “

Guthrie asked the FDA Commissioner, who would be in charge of approving any potential vaccine if he feared incorrect information about hydroxychloroquine.

“What worries me is the FDA to provide all the information about side effects, potential side effects, and effectiveness,” Hahn said. “As you know, these drugs have been approved by the FDA for other indications for several years. We know they are safe in these settings. We want to ensure that providers provide the right information so that they can make decisions with patients. “

Report typos and corrections: [email protected].




Source link